skip to main content
Idioma:
Mostrar Somente
Refinado por: autor: Bressan, R remover nível superior: Disponível na Biblioteca remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia
A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia
Material Type:
Artigo 		Adicionar ao Meu Espaço

A 6-month randomized controlled trial to test the efficacy of a lifestyle intervention for weight gain management in schizophrenia

Cecília Attux Larissa C Martini; Hélio Elkis; Sérgio Tamai; Andréa Freirias; Maria das Graças Miquelutti Camargo; Mário Dinis Mateus; Jair de Jesus Mari; André F Reis; Rodrigo A Bressan

BMC psychiatry (Online) Londres v. 13, n. 60, p. (online), 2013

Londres 2013

Acesso online. A biblioteca também possui exemplares impressos.

2
Genetic risk for Alzheimer's disease and functional brain connectivity in children and adolescents
Genetic risk for Alzheimer's disease and functional brain connectivity in children and adolescents
Material Type:
Artigo 		Adicionar ao Meu Espaço

Genetic risk for Alzheimer's disease and functional brain connectivity in children and adolescents

Luiza Kvitko Axelrud Joao Ricardo Sato; Marcos Leite Santoro; Fernanda Talarico; Daniel Samuel Pine; Luis Augusto Rohde; Andre Zugman; Edson Amaro Junior; Rodrigo Affonseca Bressan; Eurípedes Constantino Miguel Filho

Neurobiology of aging v. 82, p. 10-17, 2019

New York 2019

Acesso online. A biblioteca também possui exemplares impressos.

3
Effects of minocycline add on treatment on brain morphometry and cerebral perfusion in recent onset schizophrenia
Effects of minocycline add on treatment on brain morphometry and cerebral perfusion in recent onset schizophrenia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of minocycline add on treatment on brain morphometry and cerebral perfusion in recent onset schizophrenia

Cristiano Chaves Cristiane Reberte de Marque; João P. Maia de Oliveira; Lauro Wichert Ana; Thiago B Ferrari; Antônio Carlos dos Santos; David Araujo; João P. Machado de Sousa; Rodrigo A Bressan; Helio Elkis; José Alexandre de Souza Crippa; Francisco Silveira Guimarães; Antonio Waldo Zuardi; Glen B Baker; Serdar M Dursun; Jaime Eduardo Cecílio Hallak

Schizophenia Research Amsterdam v. 161, p. 439-445, 2015

Amsterdam 2015

Localização: FM - Fac. Medicina    (BCSEP 119 2015 ) e outros locais(Acessar)

4
Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model the SHR strain
Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model the SHR strain
Material Type:
Artigo 		Adicionar ao Meu Espaço

Sodium nitroprusside is effective in preventing and/or reversing the development of schizophrenia-related behaviors in an animal model the SHR strain

Mariana C. Diana Fernanda F Peres; Veronica Justi; Rodrigo A Bressan; Acioly L. T Lacerda; José Alexandre de Souza Crippa; Jaime Eduardo Cecílio Hallak; Vanesssa Costhek Abilio

CNS Neuroscience and Therapeutics Oxford v. 24, n. 7, p. 624-632, 2018

Oxford 2018

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 2938383 Estantes Deslizantes )(Acessar)

5
Switching from oral risperidone to flexibly dosed oral paliperidone extended-release core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study
Switching from oral risperidone to flexibly dosed oral paliperidone extended-release core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Switching from oral risperidone to flexibly dosed oral paliperidone extended-release core symptoms, satisfaction, and quality of life in patients with stable but symptomatic schizophrenia: the RISPALI study

Wagner F. Gattaz João Alberto de Oliveira Campos; Acioly L. T Lacerda; Elaine Henna; Sandra Inês Ruschel; Rodrigo A Bressan; Irismar Reis de Oliveira; Fábio Lopes Rocha; Hamilton M Grabowski; Ernindo Sacomani Jr.; Mario R Louzã; João Quevedo; Hélio Elkis; Dirceu Zorzetto Filho; Cintia de Azevedo-Marques Périco; Fábio Lorea Lawson; José Carlos Appolinário

Current Medical Research and Opinions London v. 30, n. 4, p. 695-709, 2014

London 2014

Localização: FM - Fac. Medicina    (BCSEP 239 2014 )(Acessar)

6
Mononitrate isosorbide as an adjunctive therapy in schizophrenia a randomized controlled crossover trial
Mononitrate isosorbide as an adjunctive therapy in schizophrenia a randomized controlled crossover trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mononitrate isosorbide as an adjunctive therapy in schizophrenia a randomized controlled crossover trial

Tiago Moraes Guimarães Mara R. C Guimarães; Ícaro A. F Oliveira; Renata Ferranti Leoni; Antonio Carlos dos Santos; Serdar M Dursun; José Alexandre de Souza Crippa; Rodrigo A Bressan; João Paulo Machado-de-Sousa; Acioly L. T Lacerda; Jaime Eduardo Cecilio Hallak

Journal of Clinical Psychopharmacology Philadelphia v. 41, n. 3, p. 260-266, 2021

Philadelphia 2021

Localização: FMRP - Fac. Medicina de Ribeirão Preto    (pcd 3061785 Acervo Digital )(Acessar)

7
Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder
Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Orbitofrontal thickness as a measure for treatment response classification in obsessive-compulsive disorder

Marcelo Hoexter Juliana Diniz; Antonio Lopes; Marcelo Batistuzzo; Roseli Shavitt; Darin Dougherty; Fabio Duran; Rodrigo Bressan; Geraldo Busatto; Euripides Miguel; João Sato; American College of Neuropsychopharmacology (ACNP) 2014) (53. Phoenix/Arizona

Neuropsychopharmacology New York v. 39, n. 51, p. S230-231, res. M179, 2014

New York 2014

Localização: FM - Fac. Medicina    (BCSEP 593 2014 )(Acessar)

8
Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder
Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder
Material Type:
Artigo 		Adicionar ao Meu Espaço

Differential prefrontal gray matter correlates of treatment response to fluoxetine or cognitive-behavioral therapy in obsessive–compulsive disorder

Marcelo Q. Hoexter Darin D Dougherty; Fabio L. S Duran; Antonio C Lopes; Juliana B Diniz; Marcelo C Batistuzzo; Karleyton C Evans; Rodrigo A Bressan; Geraldo F Busatto; Euripedes C Miguel

European Neuropsychopharmacology Amsterdam v. 23, n. 7, p. 569-580, 2013

Amsterdam 2013

Localização: FM - Fac. Medicina    (BCSEP 340 2013 )(Acessar)

9
Orbitofrontal thickness as a measure for treatment response prediction in obsessive–compulsive disorder
Orbitofrontal thickness as a measure for treatment response prediction in obsessive–compulsive disorder
Material Type:
Artigo 		Adicionar ao Meu Espaço

Orbitofrontal thickness as a measure for treatment response prediction in obsessive–compulsive disorder

Marcelo Q. Hoexter Juliana B Diniz; Antonio C Lopes; Marcelo C Batistuzzo; Roseli G Shavitt; Darin D Dougherty; Fabio L. S Duran; Rodrigo A Bressan; Geraldo F Busatto; Euripides C Miguel; Joao R Sato

Depression and Anxiety New York v. 32, n. 12, p. 900-908, 2015

New York 2015

Localização: FM - Fac. Medicina    (BCSEP 528 2015 )(Acessar)

10
Pretreatment Orbitofrontal Thickness as a Measure to Classify OCD Patients in Responders and Non-Responders
Pretreatment Orbitofrontal Thickness as a Measure to Classify OCD Patients in Responders and Non-Responders
Material Type:
Artigo de Congresso 		Adicionar ao Meu Espaço

Pretreatment Orbitofrontal Thickness as a Measure to Classify OCD Patients in Responders and Non-Responders

Marcelo Q. Hoexter Antonio C Lopes; Roseli G Shavitt; Marcelo C Batistuzzo; Darin D Dougherty; Juliana B Diniz; Fabio F. S Duran; Geraldo F Busatto; Rodrigo A Bressan; João R Sato; Euripedes C Miguel; Annual Scientific Convention and Meeting San Francisco) 2013 (68

Biological psychiatry New York v. 73, n. 9, suppl. 1, p. 78S, abst. 240, 2013

New York 2013

Localização: FM - Fac. Medicina    (BCSEP 268 2013 )(Acessar)

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (10)

Autor/Criador 

  1. Gadelha, A  (14)
  2. Sato, J  (14)
  3. Rohde, L  (13)
  4. Miguel, E  (13)
  5. Jackowski, A  (13)
  6. Pan, P  (12)
  7. Salum, G  (10)
  8. Hoexter, M  (10)
  9. Picon, F  (8)
  10. Lacerda, A  (8)
  11. McGuire, P  (8)
  12. Zugman, A  (8)
  13. Hallak, J  (7)
  14. Mari, J  (7)
  15. Moura, L  (7)
  16. Anés, M  (6)
  17. Crippa, J  (6)
  18. Amaro Jr.  (5)
  19. Duran, F  (5)
  20. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de2014  (3)
  2. 2014Até2014  (7)
  3. 2015Até2015  (5)
  4. 2016Até2017  (7)
  5. Após 2017  (6)
  6. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Bressan, R
  2. Gadelha, A
  3. Sato, J
  4. Rohde, L
  5. Miguel, E

Neste Assunto:

  1. Crianças
  2. Esquizofrenia
  3. Imagem Por Ressonância Magnética
  4. Adolescentes
  5. Antipsicóticos

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.